tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IRON Stock Latest News

Disc Medicine’s Promising Position in Anemia Treatment Boosts Buy Rating Amidst Competitor Setback
RatingsDisc Medicine’s Promising Position in Anemia Treatment Boosts Buy Rating Amidst Competitor Setback
5d ago
IRON
Disc Medicine Advances Bitopertin in FDA Pilot Program
PremiumCompany Announcements
Disc Medicine Advances Bitopertin in FDA Pilot Program
6d ago
8K
IRON
Evan Seigerman Recommends Buy Rating for Disc Medicine Due to Promising Phase 2 Data and Potential Stock Appreciation
PremiumRatings
Evan Seigerman Recommends Buy Rating for Disc Medicine Due to Promising Phase 2 Data and Potential Stock Appreciation
6d ago
IRON
3 ‘Strong Buy’ Stocks to Buy Today, 12/8/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today, 12/8/2025, According to Top Analysts
6d ago
BCAX
HASI
Disc Medicine’s Promising Pipeline and Strategic Expansion Drive Buy Rating
PremiumRatings
Disc Medicine’s Promising Pipeline and Strategic Expansion Drive Buy Rating
6d ago
IRON
Disc Medicine presents initial data from RALLY-MF Phase 2 trial of DISC-0974
PremiumThe FlyDisc Medicine presents initial data from RALLY-MF Phase 2 trial of DISC-0974
7d ago
IRON
Disc Medicine’s Growth Potential Driven by Innovative Treatments and Promising Market Opportunities
Premium
Ratings
Disc Medicine’s Growth Potential Driven by Innovative Treatments and Promising Market Opportunities
25d ago
IRON
Disc Medicine price target raised to $114 from $86 at Truist
Premium
The Fly
Disc Medicine price target raised to $114 from $86 at Truist
1M ago
IRON
Disc Medicine: Strong Financial Position and Promising Product Pipeline with Bitopertin’s Billion-Dollar Potential
PremiumRatings
Disc Medicine: Strong Financial Position and Promising Product Pipeline with Bitopertin’s Billion-Dollar Potential
1M ago
IRON
Disc Medicine Advances Pipeline Amid Financial Growth
PremiumCompany Announcements
Disc Medicine Advances Pipeline Amid Financial Growth
1M ago
IRON
Disc Medicine’s Promising Pipeline and Regulatory Advancements Justify Buy Rating
PremiumRatings
Disc Medicine’s Promising Pipeline and Regulatory Advancements Justify Buy Rating
1M ago
IRON
Disc Medicine reports Q3 EPS ($1.77), consensus ($1.47)
PremiumThe Fly
Disc Medicine reports Q3 EPS ($1.77), consensus ($1.47)
1M ago
IRON
Disc Medicine resumed with a Buy at Stifel
PremiumThe FlyDisc Medicine resumed with a Buy at Stifel
1M ago
IRON
Disc Medicine’s APOLLO Study: A Potential Game-Changer for EPP and XLP Treatment
Premium
Company Announcements
Disc Medicine’s APOLLO Study: A Potential Game-Changer for EPP and XLP Treatment
2M ago
IRON
Disc Medicine’s New Study on DISC-3405: A Potential Breakthrough for Sickle Cell Disease
Premium
Company Announcements
Disc Medicine’s New Study on DISC-3405: A Potential Breakthrough for Sickle Cell Disease
2M ago
IRON
Disc Medicine’s Promising Phase 2 Study on DISC-3405 for Polycythemia Vera
PremiumCompany Announcements
Disc Medicine’s Promising Phase 2 Study on DISC-3405 for Polycythemia Vera
2M ago
IRON
Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors
PremiumCompany Announcements
Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors
2M ago
IRON
Disc Medicine’s Promising EPP Treatment Study: Key Updates and Market Impact
PremiumCompany Announcements
Disc Medicine’s Promising EPP Treatment Study: Key Updates and Market Impact
2M ago
IRON
3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
PremiumMarket News
3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
2M ago
IRON
PRAX
Disc Medicine Announces $210.9M Stock Offering
PremiumCompany AnnouncementsDisc Medicine Announces $210.9M Stock Offering
2M ago
8K
IRON
Disc Medicine $250M Spot Secondary priced at $84.00
Premium
The Fly
Disc Medicine $250M Spot Secondary priced at $84.00
2M ago
IRON
Disc Medicine’s Strategic Positioning and Growth Potential Highlighted by Analyst’s Buy Rating
Premium
Ratings
Disc Medicine’s Strategic Positioning and Growth Potential Highlighted by Analyst’s Buy Rating
2M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >